BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 6382481)

  • 1. Acute myelogenous leukemia: current status of therapy in adults.
    Foon KA; Gale RP
    Recent Results Cancer Res; 1984; 93():216-39. PubMed ID: 6382481
    [No Abstract]   [Full Text] [Related]  

  • 2. Acute myelogenous leukemia: current status of therapy in children.
    Ritter J; Creutzig U; Riehm HJ; Schellong G
    Recent Results Cancer Res; 1984; 93():204-15. PubMed ID: 6382480
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of acute myelogenous leukaemia.
    Löwenberg B
    J Intern Med Suppl; 1997; 740():17-22. PubMed ID: 9350177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strategies for acute myelogenous leukemia.
    Gale RP; Butturini A
    Bone Marrow Transplant; 1991; 7 Suppl 2():58. PubMed ID: 1878721
    [No Abstract]   [Full Text] [Related]  

  • 5. Autologous bone marrow transplantation for patients with acute myelogenous leukemia in complete remission.
    Meloni G; De Fabritiis P; Petti MC; Pulsoni A; Sandrelli A; Covelli A; Simone F; Mandelli F
    Ann N Y Acad Sci; 1987; 511():483-8. PubMed ID: 3326477
    [No Abstract]   [Full Text] [Related]  

  • 6. Allogeneic versus autologous bone marrow transplantation versus chemotherapy for treatment of acute myeloid leukemia in first complete remission (BGM 84 and BGMT 87 studies). The BGMT Group.
    Reiffers J; Stoppa AM; Rigal-Huguet F; Michallet M; Marit G; Gastaut JA; Attal M; Corront B; Broustet A; Hollard D
    Bone Marrow Transplant; 1991; 7 Suppl 2():36. PubMed ID: 1878709
    [No Abstract]   [Full Text] [Related]  

  • 7. Autologous bone marrow transplantation in first remission AML--its relative value.
    de Gast GC; Zwaan FE; Hagenbeek T; Verdonck LF; Löwenberg B
    Bone Marrow Transplant; 1990 Jul; 6 Suppl 1():52-4. PubMed ID: 2202468
    [No Abstract]   [Full Text] [Related]  

  • 8. Bone marrow transplantation: its biology and role as treatment for acute and chronic leukemias.
    Champlin R; Gale RP
    Ann N Y Acad Sci; 1987; 511():447-58. PubMed ID: 2830829
    [No Abstract]   [Full Text] [Related]  

  • 9. Autologous bone marrow rescue for patients with acute myelogenous leukemia: purging with hyperthermia and ether lipid in vitro.
    Min W; Kim D; Lee J; Park J; Kim C; Kim D
    Prog Clin Biol Res; 1994; 389():197-203. PubMed ID: 7700903
    [No Abstract]   [Full Text] [Related]  

  • 10. Chemotherapy versus transplantation: I. Acute myelogenous leukemia.
    Gale RP; Butturini A
    Haematologica; 1989; 74(1):1-4. PubMed ID: 2498172
    [No Abstract]   [Full Text] [Related]  

  • 11. Allogeneic and autologous bone marrow transplantation for patients with acute non-lymphoblastic leukemia in first complete remission. The Genoa experience on 119 patients.
    Carella AM; Piatti G; Frassoni F; Maraone MP; Van Lint MT; Bacigalupo A
    Bone Marrow Transplant; 1990 Jul; 6 Suppl 1():55. PubMed ID: 2202469
    [No Abstract]   [Full Text] [Related]  

  • 12. The role of bone marrow transplantation in acute myelogenous leukemia.
    Gale RP
    Haematol Blood Transfus; 1987; 30():197-203. PubMed ID: 3305195
    [No Abstract]   [Full Text] [Related]  

  • 13. The use of cultured bone marrow cells for autologous transplantation in patients with acute myeloblastic leukemia.
    Testa NG; Coutinho L; Chang J; Morgenstern G; Scarffe JH; Dexter TM
    Haematol Blood Transfus; 1987; 31():75-8. PubMed ID: 3327789
    [No Abstract]   [Full Text] [Related]  

  • 14. [Current situation and perspective for treatment of acute myelogenous leukemia in adults].
    Fukushima T; Ueda T
    Gan To Kagaku Ryoho; 1998 Feb; 25(3):295-302. PubMed ID: 9492819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allogeneic versus autologous bone marrow transplantation (BMT) versus intensive consolidation in acute myelogenous leukemia (AML) in first remission. An EORTC-Gimema phase III trial (AML8 A). The EORTC Leukemia Cooperative Group and the GIMEMA Group.
    Zittoun R; Mandelli F; Willemze R; de Witte T; Tura S; Ferrini PR; Stryckmans P; Gattringer C; Petti MC; Solbu G
    Leukemia; 1992; 6 Suppl 2():114-5. PubMed ID: 1578909
    [No Abstract]   [Full Text] [Related]  

  • 16. Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia. European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA) Leukemia Cooperative Groups.
    Zittoun RA; Mandelli F; Willemze R; de Witte T; Labar B; Resegotti L; Leoni F; Damasio E; Visani G; Papa G
    N Engl J Med; 1995 Jan; 332(4):217-23. PubMed ID: 7808487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Post-remission treatment of acute myelogenous leukemia.
    Löwenberg B
    N Engl J Med; 1995 Jan; 332(4):260-2. PubMed ID: 7808494
    [No Abstract]   [Full Text] [Related]  

  • 18. The therapy of acute myelogenous leukemia, a major challenge of onco-hematology.
    Boiron M
    Pathol Biol (Paris); 1986 Mar; 34(3):153-6. PubMed ID: 3517783
    [No Abstract]   [Full Text] [Related]  

  • 19. Results of autologous bone marrow transplantation for acute leukaemia.
    Gulati SC; Whitmarsh K; Reich L; Berman E; Yahalom J; Yopp J; Clarkson B; Gee T
    Bone Marrow Transplant; 1989 Dec; 4 Suppl 4():61-4. PubMed ID: 2697438
    [No Abstract]   [Full Text] [Related]  

  • 20. Advances in the treatment of acute myelogenous leukemia.
    Gale RP
    N Engl J Med; 1979 May; 300(21):1189-99. PubMed ID: 372809
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.